高级搜索
大肠癌雌激素与孕激素受体检测的探讨[J]. 肿瘤防治研究, 1996, 23(1): 32-33.
引用本文: 大肠癌雌激素与孕激素受体检测的探讨[J]. 肿瘤防治研究, 1996, 23(1): 32-33.
Assay of Estrogen and progesterone Receptor in large intestine cancer[J]. Cancer Research on Prevention and Treatment, 1996, 23(1): 32-33.
Citation: Assay of Estrogen and progesterone Receptor in large intestine cancer[J]. Cancer Research on Prevention and Treatment, 1996, 23(1): 32-33.

大肠癌雌激素与孕激素受体检测的探讨

Assay of Estrogen and progesterone Receptor in large intestine cancer

  • 摘要: 本文应用E2-HRP、Pg-HRP亲合组化法对80例大肠癌切除标本进行了ER、PgR检测,结果大肠癌的ER、PgR阳性率分别为45.0%和36.3%,大肠癌ER、PgR阳性率与病人性别,肿瘤部位、大体类型,淋巴结转移无关。而绝经后的大肠癌患者,年龄越大,肿瘤分化程度越高,阳性率亦越高,提示ER、PgR水平高低可作为选择内分泌治疗和预测病人预后的参考指标。

     

    Abstract: Eighty colo-rectal cancer tissues were assayed by using E2-HRP and Pg-HRP affinity histochemical method for contents of ER and PgR.The positiue rates of ER and PgR in Large intestine cancer were 45. 0% and 36. 3% respectively. There were no correlation between ER or PgR positivity and the sex of patient or location of tumor, metastasis of lymph nodes, type of tumor. The higher patients age and the better differentiation of cancer was the higher of the level of the ER and PgR contents would be.It is indicated that large intestine cancer may be an estrogen dependent tumor and endocrinotherapy might be of help.

     

/

返回文章
返回